Wall Street Bulls Look Optimistic About Bank of America (BAC): Should You Buy?

04.12.25 15:30 Uhr

Werte in diesem Artikel
Aktien

46,49 EUR 0,19 EUR 0,41%

Indizes

PKT PKT

18.185,9 PKT 164,3 PKT 0,91%

3.432,7 PKT -6,4 PKT -0,19%

6.843,2 PKT -6,5 PKT -0,09%

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Bank of America (BAC).Bank of America currently has an average brokerage recommendation (ABR) of 1.57, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc.) made by 27 brokerage firms. An ABR of 1.57 approximates between Strong Buy and Buy.Of the 27 recommendations that derive the current ABR, 16 are Strong Buy and six are Buy. Strong Buy and Buy respectively account for 59.3% and 22.2% of all recommendations.Brokerage Recommendation Trends for BACCheck price target & stock forecast for Bank of America here>>>While the ABR calls for buying Bank of America, it may not be wise to make an investment decision solely based on this information. Several studies have shown limited to no success of brokerage recommendations in guiding investors to pick stocks with the best price increase potential.Do you wonder why? As a result of the vested interest of brokerage firms in a stock they cover, their analysts tend to rate it with a strong positive bias. According to our research, brokerage firms assign five "Strong Buy" recommendations for every "Strong Sell" recommendation.In other words, their interests aren't always aligned with retail investors, rarely indicating where the price of a stock could actually be heading. Therefore, the best use of this information could be validating your own research or an indicator that has proven to be highly successful in predicting a stock's price movement.With an impressive externally audited track record, our proprietary stock rating tool, the Zacks Rank, which classifies stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), is a reliable indicator of a stock's near-term price performance. So, validating the Zacks Rank with ABR could go a long way in making a profitable investment decision.Zacks Rank Should Not Be Confused With ABRIn spite of the fact that Zacks Rank and ABR both appear on a scale from 1 to 5, they are two completely different measures.Broker recommendations are the sole basis for calculating the ABR, which is typically displayed in decimals (such as 1.28). The Zacks Rank, on the other hand, is a quantitative model designed to harness the power of earnings estimate revisions. It is displayed in whole numbers -- 1 to 5.It has been and continues to be the case that analysts employed by brokerage firms are overly optimistic with their recommendations. Because of their employers' vested interests, these analysts issue more favorable ratings than their research would support, misguiding investors far more often than helping them.On the other hand, earnings estimate revisions are at the core of the Zacks Rank. And empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.Furthermore, the different grades of the Zacks Rank are applied proportionately across all stocks for which brokerage analysts provide earnings estimates for the current year. In other words, at all times, this tool maintains a balance among the five ranks it assigns.There is also a key difference between the ABR and Zacks Rank when it comes to freshness. When you look at the ABR, it may not be up-to-date. Nonetheless, since brokerage analysts constantly revise their earnings estimates to reflect changing business trends, and their actions get reflected in the Zacks Rank quickly enough, it is always timely in predicting future stock prices.Should You Invest in BAC?Looking at the earnings estimate revisions for Bank of America, the Zacks Consensus Estimate for the current year has increased 0.8% over the past month to $3.8.Analysts' growing optimism over the company's earnings prospects, as indicated by strong agreement among them in revising EPS estimates higher, could be a legitimate reason for the stock to soar in the near term.The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #2 (Buy) for Bank of America. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Therefore, the Buy-equivalent ABR for Bank of America may serve as a useful guide for investors.Zacks' Research Chief Picks Stock Most Likely to "At Least Double"Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.See Our Top Stock to Double (Plus 4 Runners Up) >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Bank of America Corporation (BAC): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Bank of America und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Bank of America

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Bank of America

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Bank of America Corp.

Wer­bung

Analysen zu Bank of America Corp.

DatumRatingAnalyst
16.04.2024Bank of America OutperformRBC Capital Markets
15.04.2021Bank of America OutperformRBC Capital Markets
19.01.2021Bank of America NeutralUBS AG
14.10.2020Bank of America OutperformRBC Capital Markets
05.10.2020Bank of America OutperformRBC Capital Markets
DatumRatingAnalyst
16.04.2024Bank of America OutperformRBC Capital Markets
15.04.2021Bank of America OutperformRBC Capital Markets
14.10.2020Bank of America OutperformRBC Capital Markets
05.10.2020Bank of America OutperformRBC Capital Markets
18.06.2019Bank of America OutperformBMO Capital Markets
DatumRatingAnalyst
19.01.2021Bank of America NeutralUBS AG
15.04.2020Bank of America NeutralUBS AG
04.04.2019Bank of America HoldHSBC
02.01.2019Bank of America Equal WeightBarclays Capital
02.01.2018Bank of America Equal WeightBarclays Capital
DatumRatingAnalyst
21.12.2012Bank of America verkaufenJMP Securities LLC
23.01.2012Bank of America verkaufenIndependent Research GmbH
27.10.2011Bank of America verkaufenRaiffeisen Centrobank AG
20.10.2011Bank of America verkaufenIndependent Research GmbH
14.09.2011Bank of America verkaufenIndependent Research GmbH

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Bank of America Corp. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen